EGT-201

N/A

Report date: 2024/09/04 13:35:02

Base Information

Drug NameEGT-201
Drug Alias NameEGT-201
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionAlpha-N-acetylglucosaminidase replacementsGene transference
TargetsAlpha-N-acetylglucosaminidase
Therapy Area/IndicationsMucopolysaccharidosis III
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversitat Autonoma De BarcelonaEsteve Healthcare SL
China Registration ClassN/A

Develop Information

Active CompaniesEsteve Healthcare SLUniversitat Autonoma De Barcelona
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis III
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A